Vioxx Research Today is a free monthly online journal that collates and summarizes the latest research about Vioxx, including details on osteoarthritis, side-effects, trials, stroke, heart attack.

Volume 4 (2007), Issue 12 (December)

1. Orthodontic tooth movement after different coxib therapies.
   Eur J Orthod, 29(6): 596-9. [Abstract] [Full-text]
2. Preclinical pharmacology profile of CS-706, a novel cyclooxygenase-2 selective inhibitor, with potent antinociceptive and anti-inflammatory effects.
   Eur J Pharmacol, 578(1): 76-86. [Abstract] [Full-text]
3. Behavioral characterization and effect of clinical drugs in a rat model of pain following spinal cord compression.
   Brain Res, 1185: 117-28. [Abstract] [Full-text]
4. Limited role of COX-2 in HIV Tat-induced alterations of tight junction protein expression and disruption of the blood-brain barrier.
   Brain Res, 1184: 333-44. [Abstract] [Full-text]
5. Effects of nonsteroidal anti-inflammatory drugs on the expression of urokinase plasminogen activator and inhibitor and gelatinases in the early osteoarthritic knee of humans.
   Clin Biochem, 41(1): 109-16. [Abstract] [Full-text]
6. Large-scale stopping and switching treatment with COX-2 inhibitors after the rofecoxib withdrawal.
   Pharmacoepidemiol Drug Saf, 17(1): 9-19. [Abstract] [Full-text]
7. Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor increases pentylenetetrazol seizure threshold in mice: Possible involvement of adenosinergic mechanism.
   Epilepsy Res, 78(1): 60-70. [Abstract] [Full-text]
8. Are COX-2 inhibitors preferable to non-selective non-steroidal anti-inflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin?
   Lancet, 370(9605): 2138-51. [Abstract] [Full-text]
9. Evaluation of [(11)C]rofecoxib as PET tracer for cyclooxygenase 2 overexpression in rat models of inflammation.
   Nucl Med Biol, 35(1): 35-42. [Abstract] [Full-text]
10. Lipoperoxidation and Cyclooxygenase Enzyme Inhibitory Piperidine Alkaloids from Cassia spectabilis Green Fruits.
    J Nat Prod, 70(12): 2026-8. [Abstract] [Full-text]
11. Celecoxib transiently inhibits cellular protein synthesis.
    Biochem Pharmacol, 75(2): 395-404. [Abstract] [Full-text]
12. The differential effects of bupivacaine and lidocaine on prostaglandin E2 release, cyclooxygenase gene expression and pain in a clinical pain model.
    Anesth Analg, 106(1): 321-7, table of contents. [Abstract] [Full-text]

© 2004-2008 Vioxx Research Today. All Rights Reserved.